Trial reportPloS one2018
Knowledge, attitudes and awareness of the human papillomavirus among health professionals in New Zealand.
Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
30 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.
- Healthcare worker practices for HPV vaccine recommendation: A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2024Pooled it
- Determinants of cervical cancer screening and HPV vaccination among female medical practitioners in Punjab, India.Scientific reports · 2026Article
- Article
- Awareness among nurses concerning the human papilloma virus in the selected clinics in Vhembe district of Limpopo Province, South Africa.Frontiers in public health · 2025Article
- Healthcare professionals' knowledge and attitude toward Human papillomavirus vaccination: A critical appraisal of research evidence.Journal of education and health promotion · 2025Review
- Knowledge, Attitudes, and Perceptions of African Parents in New Zealand Towards the Human Papillomavirus Vaccine.Cureus · 2024Article
- Article
- The effect of participatory action research on HPV primary preventive measures among in-school adolescents in Benue State, Nigeria.BMC public health · 2024Article
- Varying behavioral differences and correlates of HPV infection among young adolescents in Benue state, Nigeria.BMC public health · 2024Article
- Article
- Article
- Awareness of Human Papillomavirus among Male and Female University Students in Saudi Arabia.Healthcare (Basel, Switzerland) · 2023Article
- Strategies to eliminate cervical cancer in China.Frontiers in oncology · 2023Review
- Knowledge about human papillomavirus transmission and prevention among physicians in Rio de Janeiro state, Brazil.Revista da Associacao Medica Brasileira (1992) · 2023Article
- Human Papillomavirus, Related Diseases, and Vaccination: Knowledge and Awareness Among Health Care Students and Professionals in Nepal.Journal of cancer education : the official journal of the American Association for Cancer Education · 2022Article
- Review
- Human papillomavirus vaccination related knowledge, and recommendations among healthcare providers in Southern China: a cross-sectional survey.BMC women's health · 2022Article
- Vaccine hesitancy and HPV vaccine uptake among male and female youth in Switzerland: a cross-sectional study.BMJ open · 2022Article
- Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt.Maternal and child health journal · 2022Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHuman papillomavirus (HPV) is a common sexually transmitted infection that is implicated in 99.7% of cervical cancers and several other cancers that affect both men and women. Despite the role that HPV plays in an estimated 5% of all cancers and the evolving role of HPV vaccination and testing in protecting the public against these cancers, preliminary research in New Zealand health professionals suggest knowledge about HPV may not be sufficient.
methodsA total of 230 practice nurses, smear takers and other clinical and laboratory staff who attended a range of training events completed a cross-sectional survey between April 2016 and July 2017. The survey explored four broad areas: demographics and level of experience, HPV knowledge (general HPV knowledge, HPV triage and test of cure (TOC) knowledge and HPV vaccine knowledge), attitudes towards the HPV vaccine and self-perceived adequacy of HPV knowledge.
resultsThe mean score on the general HPV knowledge questions was 13.2 out of 15, with only 25.2% of respondents scoring 100%. In response to an additional question, 12.7% thought (or were unsure) that HPV causes HIV/AIDS. The mean score on the HPV Triage and TOC knowledge questions was 7.4 out of 10, with only 9.1% scoring 100%. The mean score on the HPV vaccine knowledge questions was 6.0 out of 7 and 44.3% scored 100%. Only 63.7% of respondents agreed or strongly agreed that they were adequately informed about HPV, although 73.3% agreed or strongly agreed that they could confidently answer HPV-related questions asked by patients. Multivariate analyses revealed that knowledge in each domain predicted confidence in responding to patient questions. Furthermore, the number of years since training predicted both HPV knowledge and Triage and TOC knowledge. DISCUSSION: Although overall level of knowledge was adequate, there were significant gaps in knowledge, particularly about the role of HPV testing in the New Zealand National Cervical Screening Programme. More education is required to ensure that misinformation and stigma do not inadvertently result from interactions between health professionals and the public.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.